Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma-Reference-Cited by-同舟云学术

Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma

Published:2018-07-03 Issue: Volume:8 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Warren Katherine Elizabeth

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference66 articles.

1. Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes;Castel;Acta Neuropathol,2015

2. Combination of EZH2 inhibitor and BET inhibitor for treatment of diffuse intrinsic pontine glioma;Zhang;Cell Biosci,2017

3. Plasma and cerebrospinal fluid pharmacokinetics of gemcitabine after intravenous administration in nonhuman primates;Kerr;Cancer Chemother Pharmacol,2001

4. A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma;Veldhuijzen van Zanten;J Neurooncol,2017

5. A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors;Becher;PLoS One,2017

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPM1D truncation-associated overexpression of the stress-related protein NQO1 confers sensitivity to the bioactivatable drug IB-DNQ in diffuse intrinsic pontine glioma;2024-09-06

2. Pediatric Hemispheric High-Grade Gliomas and H3.3-G34 Mutation: A Review of the Literature on Biological Features and New Therapeutic Strategies;Genes;2024-08-06

3. Glioma stem cells remodel immunotolerant microenvironment in GBM and are associated with therapeutic advancements;Cancer Biomarkers;2024-08-04

4. H3K27-Altered Diffuse Midline Glioma of the Brainstem: From Molecular Mechanisms to Targeted Interventions;Cells;2024-06-28

5. Diffuse midline glioma of the brainstem: genetic features, complications and treatment prospects;Head and Neck Tumors (HNT);2024-06-27